| Document |
Document Title |
|
WO/2024/084475A2 |
The present disclosure relates to metal organic frameworks (MOFs). Specifically, the present disclosure relates to a surface-coated porous ZnTPA (Zinc-terephthalic acid) MOFs with Zn(II) metal center, terephthalic acid (TPA) ligand moiet...
|
|
WO/2024/083545A1 |
The present invention relates to a process for providing 4-chloro-2-(trifluoromethyl)phenyl Grignard compound. Further, the present invention relates to the process for preparation of 4-chloro-2-(trifluoromethyl)phenyl compounds from 4-c...
|
|
WO/2024/059951A1 |
This invention provides compound having a structure of Formulas I-VI. Uses of such compounds for treatment of various indications that would benefit from modulation of the androgen receptor, including prostate cancer. Also provided are m...
|
|
WO/2024/053091A1 |
[Problem] The purpose of the present invention is to develop a low-cost and higher aspect ratio material that is available as a substitute for conventional high aspect ratio magnesium hydroxide which requires a large amount of a monocarb...
|
|
WO/2024/048409A1 |
Provided is a composite obtained by bonding, with high strength, a support having a metal part and a metal-organic framework (MOF). The composite comprises a support having a metal part and a metal-organic framework formed on the surfa...
|
|
WO/2024/046108A1 |
A Zn-based organic coordination nanoparticle and a preparation method therefor, a photoresist composition containing same, and a use thereof. The Zn-based organic coordination nanoparticle is obtained by mixing and stirring a zinc-contai...
|
|
WO/2024/045401A1 |
Provided in the present invention are a crystal compound, a preparation method, and the use of same in X-ray direct detection and imaging, relating to the technical field of crystal synthesis. Specifically, the molecular formula of the c...
|
|
WO/2024/024818A1 |
[Problem] To provide a simpler method for producing a high-quality metal-organic structure. [Solution] The method for producing a metal-organic structure according to the present invention comprises: providing a stirrer equipped with a...
|
|
WO/2024/002889A1 |
The invention relates to compounds of formula (I) : as well as stereoisomeric forms, mixtures of stereoisomeric forms, and salts thereof, wherein R1, R2, R3, R4 and R5 are as defined in claim 1. Compounds of formula (I) are particularly ...
|
|
WO/2023/250518A2 |
Provided herein are novel catalyst complexes useful in ring-opening polymerization of lactones particularly β-lactones. The catalyst complexes have a structural formula that includes a ligand and metal precursor of zinc and aluminum. Th...
|
|
WO/2023/248723A1 |
Provided is an immobilized zinc complex comprising at least: a compound represented by general formula (1) (where R1 and R2 each represent a monovalent hydrocarbon group, R3 represents a divalent hydrocarbon group, R4 to R7 each represen...
|
|
WO/2023/244050A1 |
The present invention relates to a method for controlling the size of a metal-organic framework. More specifically, the present invention provides: a method for controlling the size of a metal-organic framework, the method comprising a s...
|
|
WO/2023/242454A1 |
The present invention discloses a hybrid material for detecting acid and base vapours, said material comprising a metal-organic framework and at least one colouring agent encapsulated in the pores of said metal-organic framework having p...
|
|
WO/2023/238911A1 |
A method for producing a magnesium compound, wherein at least one of magnesium metal, an alcohol, and iodine is mixed with a fluorinated alcohol represented by formula (1) and a solvent to thereby form a magnesium precursor represented b...
|
|
WO/2023/238162A1 |
The present disclosure provides a Magnesium-Air (Mg-Air) fuel cell, wherein the cathode comprises hydroxyl-ion-doped material, a Magnesium anode, and an electrolyte containing a Mg-rich material. In an aspect of the disclosure, the hydro...
|
|
WO/2023/219584A1 |
The invention relates to a thiosemicarbazone complex compound with anti¬ inflammatory and wound healing properties, which inhibits the 3CL main protease enzyme of SARS-CoV-2 virus and IL-8 cytokine of human bronchial epithelial cells. T...
|
|
WO/2023/199298A1 |
The present invention relates to poly(melamine-silicate) derivatives as biocidal disinfection and decontamination agents, and to methods for their production and use. More specifically, the invention relates to halogenated adducts of pol...
|
|
WO/2023/176918A1 |
The purpose of the present invention is to provide a metal-organic framework that exhibits an excellent adsorption performance for adsorption target substances. The present invention is a metal-organic framework that has a decomposition ...
|
|
WO/2023/176919A1 |
The purpose of the present invention is to provide an MOF having excellent heat resistance. The metal-organic framework has a structure SM-x which is composed of: an organic ligand; a structure Sx consisting of at least one among O2-, OH...
|
|
WO/2023/157982A1 |
The purpose of the present disclosure is to provide a method for isolating a fluorocarbon having one carbon atom. A fluorocarbon isolation method according to the present disclosure comprises isolating a fluorocarbon having n carbon at...
|
|
WO/2023/152332A1 |
The current invention relates to a method for the production of at least one organometallic compound comprising: filling solid metal particulates or metal containing solid particulates into a reactor column obtaining a metal bed; continu...
|
|
WO/2023/119507A1 |
[Problem] To increase the number of catechol sites for modification in a metal-organic framework. [Solution] This catechol-modified metal-organic framework comprises: a metal organic framework that contains a central metal and an organic...
|
|
WO/2023/119508A1 |
[Problem] To increase metal sites that modify a metal organic framework to increase the adsorption amount of a gas. [Solution] Provided is a metal-modified metal organic framework which comprises a metal organic framework containing a ce...
|
|
WO/2023/118454A1 |
Metal-organic framework material (MOF), comprising at least one metal center and at least one organic compound selected among the compounds according to formula (I): (I) - wherein n is from 1 to 2, - R is –(CH2-CH2-O)m-CH3 with m from ...
|
|
WO/2023/120645A1 |
The purpose of the present invention is to newly provide an organic zinc compound that can be used to synthesize a special amino acid. Provided are an organic zinc compound and a production method for the organic zinc compound.
|
|
WO/2023/106883A1 |
The present invention discloses a novel compound, a method for producing same, and a pharmaceutical composition containing same. The compound according to the present invention is represented by chemical formula 1. In chemical formula 1,...
|
|
WO/2023/106616A1 |
Disclosed in the present invention are a novel compound, a preparation method therefor, and a pharmaceutical composition comprising same. The compound of the present invention is represented by the following chemical formula 1. [Chemical...
|
|
WO/2023/096802A1 |
The disclosure provides methodology for the synthesis of mono-alkylated cyclopentadiene structures, which can be obtained via fulvene intermediates. In one embodiment, the cyclopentadiene ring is substituted with a trialkylsilyl moiety, ...
|
|
WO/2023/086062A1 |
Invention relates to use of antitumoral effective benzimidazole metal complex containing zinc having antitumoral effect, in treatment of cancer. The invention particularly relates to use of 1-(4-chlorobenzyl)benzimidazole and 1-(4-methyl...
|
|
WO/2023/080505A1 |
The present invention relates to an organometallic compound, a method for preparing same, and a method for preparing a thin film using same and, more specifically, to an organometallic compound, a method for preparing same, and a method ...
|
|
WO/2023/071328A1 |
Disclosed is a method for synthesizing 8-amino-1-{[2-(trimethylsilyl)ethoxy]methoxy}octane-3-one, which belongs to the technical field of pharmaceutical chemical synthesis. The method comprises the steps of: firstly, protecting diphenylm...
|
|
WO/2023/071855A1 |
Disclosed are a class of hydrazone-based Zn (II) coordination complex photochromic material, a preparation and a use thereof. Said class of material is a hydrazone-based terpyridine ligand, hydrazone is used as a basis of an optical swit...
|
|
WO/2023/069767A1 |
This present disclosure is directed to methods for detecting and quantifying radioisotopes ( e.g., radiopharmaceuticals) in a liquid and compositions involving the same. Metal-organic frameworks (MOFs) can be synthesized and used for mea...
|
|
WO/2023/058659A1 |
The purpose of the present invention is to provide: a new porous three-dimensional network structure applicable to a crystalline sponge method; a method for producing the porous three-dimensional network structure; and a new structural a...
|
|
WO/2023/036350A1 |
The present invention relates to compounds of general formula (I) for use as complexing agents. The invention further relates to the coordination compounds thereof, peptide conjugates, method of their preparation and use thereof.
|
|
WO/2023/028644A1 |
The present application relates to a metal organic framework (MOF) glass composite comprising metal halide perovskite, and a method for its preparation.
|
|
WO/2023/029620A1 |
The present application provides an organomagnesium compound having a structure represented by the following structural formula (1): the organomagnesium compound is a liquid in a working state, has a stable high saturation vapor pressure...
|
|
WO/2023/022016A1 |
The present invention is a carboxylic acid zinc salt used in manufacturing semiconductor nanoparticles, the carboxylic acid zinc salt being characterized by: being a zinc salt of a carboxylic acid; the proportion of C8-10 carboxylic acid...
|
|
WO/2023/006722A1 |
The invention relates to a process for the manufacturing of a solution of a dimeric gadolinium complex, such as [μ-[1-[bis[2-(hydroxy-κO)-3-[4,7,10-tris[(carboxy-κO)meth
yl]-1,4,7,10-tetraazacyclododec-1-yl-κN1,κN4,κN7,κN10]pr
opy...
|
|
WO/2022/257895A1 |
The present invention relates to an intermediate for fulvestrant and a preparation method therefor. Specifically, the present invention relates to a compound of formula V and a preparation method therefor, wherein R1 is hydrogen or hydro...
|
|
WO/2022/256897A1 |
The present disclosure is directed to chelated nutrients having a structure [M(Ligand 1)(Ligand 2)]2Y, wherein: M is a metal selected from the group consisting of Cu, Mn, Zn, Co, Ni, Mg, Ca and Fe; Ligand 1 is glutamic acid; Ligand 2 is ...
|
|
WO/2022/224950A1 |
Provided is a method for producing an organic compound, said method including a step for repeating an operation in which a liquid containing an organic solvent is passed through a packed column packed with magnesium, a material containin...
|
|
WO/2022/196796A1 |
The first problem addressed by the present invention is to provide a simple method for producing an organic metal nucleophilic agent, the method being reduced in environmental load by reducing the amount of an organic solvent used therei...
|
|
WO/2022/190877A1 |
Provided is a thin film-forming starting material for use in an atomic layer deposition method, which contains a compound represented by general formula (1). (In formula (1), R1, R2 and R3 independently represent a linear or branched alk...
|
|
WO/2022/175927A1 |
Embodiments of the invention generally relate to a method of preparing a metal organic framework (MOF), and specifically a zinc MOF having the formula Zn2Ht2Ox. The method generally comprises contacting at least one cycloazocarbyl compou...
|
|
WO/2022/175111A1 |
The invention relates to a process for preparing compounds of the general formula MAYn(AzuH) (I), where MA = alkali metal, Y = neutral ligand, n = 0, 1, 2, 3 or 4. AzuH is azulene (bicyclo[5.3.0]decapentaene) or an azulene derivative tha...
|
|
WO/2022/176961A1 |
Disclosed is a compound represented by formula (1). In formula (1), n represents an integer of 0-5. Q1, Q2, Q3, and Q4 represent a moiety selected from group A, a moiety selected from group B, a moiety represented by formula (C1), or the...
|
|
WO/2022/165004A1 |
The present invention provides modified alphaviruses and compositions, methods, and kits for preparing and using, in particular AAV viral particles pseudotyped with capsids, in particular for use in gene therapy and/or diagnostics.
|
|
WO/2022/164213A1 |
The present invention relates to a porous carbon structure and a manufacturing method therefor. More specifically, the porous carbon structure comprises a core-shell structured MOF, in which a first MOF contained in a core and a second M...
|
|
WO/2022/152879A1 |
The present invention is directed to solvated crystalline polynuclear metal complexeswhich solvation is with a polar solvent or a mixture of polar and non-polar solvent. These polar solvated crystalline metal complexes of the present inv...
|
